Skip to main content
SpringerLink
Log in

Contraccezione ormonale maschile

  • Published:
L’Endocrinologo Aims and scope

Riassunto

La somministrazione combinata di androgeno e di un progestinico induce una profonda soppressione della spermatogenesi, rappresentando quindi un promettente regime contraccettivo per l’uomo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Glasier AF, Anakwe R, Everington D, Martin CW, van der Spuy Z, Cheng L, Ho PC, Anderson RA. Would women trust their partners to use a male pill? Hum Reprod 15: 646, 2000.

    Article  CAS  PubMed  Google Scholar 

  2. Matsumoto AM, Bremner WJ. Endocrine control of human spermatogenesis. J Steroid Biochem 33: 789, 1989.

    Article  CAS  PubMed  Google Scholar 

  3. WHO Task force on methods for the regulation of male fertility. Rates of testosterone-induced suppression to severe oligozoo-spermia or azoospermia in two multinational clinical studies. Int J Androl 18: 157, 1995.

    Google Scholar 

  4. Bebb RA, Anawalt BD, Christesen RB, Paulsen CA, Bremner WJ, Matsumoto AM. Combined administration of levonor-gestrel and testosterone induces more rapid effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 81: 757, 1996.

    CAS  PubMed  Google Scholar 

  5. Anawalt BD, Bebb A, Bremner WJ, Matsumoto AM. A lower dosage levonor-gestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations. J Androl 20: 407, 1999.

    CAS  PubMed  Google Scholar 

  6. Meriggiola MC, Bremner WJ, Paulsen CA, Valdiserri A, Incorvaia L, Motta R, Pavani A, Capelli M, Flamigni C. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. J Clin Endocrinol Metab 81: 3018, 1996.

    CAS  PubMed  Google Scholar 

  7. Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C. Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Hum Reprod 13: 1225, 1998.

    Article  CAS  PubMed  Google Scholar 

  8. Wu WCF, Balasubramanian R, Mulders TMT, Coelingh-Bennink HJT. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis and lipid metabolism. J Clin Endocrinol Metab 84: 112, 1999.

    CAS  PubMed  Google Scholar 

  9. Anawalt BD, Herbst KL, Matsumoto AM, Mulders TM, Coelingh-Bennink HJ, Bremner WJ. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression. Fertil Steril 74: 707, 2000.

    Article  CAS  PubMed  Google Scholar 

  10. Kamischke A, Nieschlag E. New testosterone preparations for male contraceptive regimens. In: Francavilla F, Francavilla S, Forti G (Eds). Proceedings of the 1st European Congress of Andrology, L’Aquila, Italy, 24–27 March 2000, p. 481.

  11. Kamischke A, Venherm S, Ploger D, von Eckardstein S, Nieschlag E. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. J Clin Endocrinol Metab 86: 303, 2000.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I Clinica Ostetrica e Ginecologica Ospedale Sant’Orsola, Università degli Studi di Bologna, Via Massarenti, 13, 40138, Bologna, Italia

    Maria Cristina Meriggiola, Antonietta Costantino & Silvia Cerpolini

Authors
  1. Maria Cristina Meriggiola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonietta Costantino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silvia Cerpolini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Cristina Meriggiola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meriggiola, M.C., Costantino, A. & Cerpolini, S. Contraccezione ormonale maschile. L’Endocrinologo 2, 48–52 (2001). https://doi.org/10.1007/BF03344386

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03344386

Search

Navigation